Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Metastatic Melanoma Stage IV”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT00316901
What this trial is testing

Positron Emission Tomography and CT Scan in Predicting Response in Patients With Metastatic Melanoma or Kidney Cancer Who Are Undergoing Cellular Adoptive Immunotherapy on a Surgery Branch Clinical Trial

Who this might be right for
Kidney CancerMelanoma (Skin)
National Institutes of Health Clinical Center (CC) 70
Early research (Phase 1)Study completedNCT00029900
What this trial is testing

ADI-PEG in Patients With Metastatic Melanoma

Who this might be right for
MelanomaNeoplasm Metastasis
FDA Office of Orphan Products Development 15
Large-scale testing (Phase 3)Active Not RecruitingNCT02506153
What this trial is testing

Physician/Patient Choice of Either High-Dose Recombinant Interferon Alfa-2B or Ipilimumab, Versus Pembrolizumab in Treating Patients With Stage III-IV High Risk Melanoma That Has Been Removed by Surgery

Who this might be right for
Clinical Stage III Cutaneous Melanoma AJCC v8Clinical Stage IV Cutaneous Melanoma AJCC v8Metastatic Cutaneous Melanoma+6 more
National Cancer Institute (NCI) 1,301
Testing effectiveness (Phase 2)Study completedNCT00071981
What this trial is testing

Vaccine Therapy Using Melanoma Peptides for Cytotoxic T Cells and Helper T Cells in Treating Patients With Metastatic Melanoma

Who this might be right for
Melanoma (Skin)
Eastern Cooperative Oncology Group 175
Testing effectiveness (Phase 2)Study completedNCT03679767
What this trial is testing

INCMGA00012 in Participants With Selected Solid Tumors (POD1UM-203)

Who this might be right for
Metastatic Non-small Cell Lung CancerLocally Advanced Urothelial CancerMetastatic Urothelial Cancer+4 more
Incyte Corporation 121
Testing effectiveness (Phase 2)Study completedNCT02902029
What this trial is testing

Evaluating the Efficacy and Safety of a Sequencing Schedule of Cobimetinib Plus Vemurafenib Followed by Immunotherapy With an Anti- PD-L1 Antibody in Patients With Unresectable or Metastatic BRAF V600 Mutant Melanoma

Who this might be right for
Malignant Melanoma
University Hospital, Essen 186
Not applicableStudy completedNCT03225365
What this trial is testing

Nivolumab +/- Ipilimumab Immunomonitoring in Metastatic Melanoma

Who this might be right for
Metastatic Melanoma
Hospices Civils de Lyon 5
Not applicableActive Not RecruitingNCT04314401
What this trial is testing

National Cancer Institute "Cancer Moonshot Biobank"

Who this might be right for
Acute Myeloid LeukemiaAnatomic Stage III Breast Cancer AJCC v8Anatomic Stage IV Breast Cancer AJCC v8+26 more
National Cancer Institute (NCI) 1,600
Testing effectiveness (Phase 2)Study completedNCT01164007
What this trial is testing

Bevacizumab (Avastin) in Combination With Dacarbazine in Participants With Unresectable/Metastatic Melanoma

Who this might be right for
Malignant Melanoma
Hoffmann-La Roche 40
Early research (Phase 1)Ended earlyNCT01835184
What this trial is testing

Cabozantinib-S-Malate and Vemurafenib in Treating Patients With Solid Tumors or Melanoma That is Metastatic or That Cannot Be Removed By Surgery

Who this might be right for
Recurrent MelanomaStage IIIA MelanomaStage IIIB Melanoma+3 more
National Cancer Institute (NCI) 5
Testing effectiveness (Phase 2)Study completedNCT00658437
What this trial is testing

CY503 for the Treatment of Malignant Melanoma Stage IV After Failure of Prior Therapy

Who this might be right for
Melanoma
Cytavis Biopharma GmbH 31
Testing effectiveness (Phase 2)Study completedNCT00096083
What this trial is testing

Hepatic Arterial Infusion of Melphalan With Hepatic Perfusion in Treating Patients With Unresectable Liver Cancer

Who this might be right for
Cancer
Delcath Systems Inc. 56
Early research (Phase 1)Active Not RecruitingNCT03161431
What this trial is testing

SX-682 Treatment in Subjects With Metastatic Melanoma Concurrently Treated With Pembrolizumab

Who this might be right for
Melanoma Stage IIIMelanoma Stage IV
Syntrix Biosystems, Inc. 77
Testing effectiveness (Phase 2)Temporarily pausedNCT00033956
What this trial is testing

Evaluation of M40403 for the Prevention of Dose Limiting Toxicities of High Dose IL-2

Who this might be right for
IL-2 Induced Hypotension
MetaPhore Pharmaceuticals 48
Early research (Phase 1)Ended earlyNCT01409174
What this trial is testing

IPI Biochemotherapy for Chemonaive Patients With Metastatic Melanoma

Who this might be right for
Melanoma
M.D. Anderson Cancer Center 19
Early research (Phase 1)Looking for participantsNCT04119024
What this trial is testing

Gene Modified Immune Cells After Conditioning Regimen for the Treatment of Stage IIIC or IV Melanoma or Metastatic Solid Tumors

Who this might be right for
Metastatic Malignant Solid NeoplasmMetastatic MelanomaPathologic Stage IIIC Cutaneous Melanoma AJCC v8+14 more
Anusha Kalbasi 18
Early research (Phase 1)Study completedNCT00324623
What this trial is testing

Cyclophosphamide and Fludarabine Followed by Cellular Adoptive Immunotherapy and Vaccine Therapy in Patients With Metastatic Melanoma

Who this might be right for
Melanoma (Skin)
Prof. Serge Leyvraz 8
Not applicableUnknownNCT05402059
What this trial is testing

Clinical Outcomes and Biomarkers in Patients With Stage 0-IV Melanoma in Real Clinical Practice

Who this might be right for
MelanomaMelanoma (Skin)Melanoma, Uveal+5 more
MelanomaPRO, Russia 1,570
Early research (Phase 1)Study completedNCT00317759
What this trial is testing

Fludarabine Followed By Adoptive Immunotherapy in Treating Patients With Stage IV Melanoma

Who this might be right for
Melanoma (Skin)
Fred Hutchinson Cancer Center 12
Testing effectiveness (Phase 2)UnknownNCT00811759
What this trial is testing

Sorafenib and Temozolomide in Treating Patients With Stage III or Stage IV Melanoma

Who this might be right for
Melanoma (Skin)
Gustave Roussy, Cancer Campus, Grand Paris 58
Next Page